A detailed history of Td Asset Management Inc transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Td Asset Management Inc holds 162,400 shares of ROIV stock, worth $2.88 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
162,400
Holding current value
$2.88 Million
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 28, 2025

BUY
$9.08 - $11.62 $1.47 Million - $1.89 Million
162,400 New
162,400 $1.83 Million
Q1 2024

May 08, 2024

SELL
$9.87 - $11.8 $3.98 Million - $4.75 Million
-402,892 Reduced 81.54%
91,192 $961,000
Q4 2023

Feb 12, 2024

SELL
$8.38 - $11.58 $6.08 Million - $8.4 Million
-725,496 Reduced 59.49%
494,084 $5.55 Million
Q3 2023

Oct 27, 2023

BUY
$9.76 - $13.19 $11.9 Million - $16.1 Million
1,219,580 New
1,219,580 $14.2 Million

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $12.5B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Td Asset Management Inc Portfolio

Follow Td Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.